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Graphical abstract :
Spirobicyclic diamines 1: Synthesis of proline-derived spirolactams via thermal intramolecular
ester aminolysis.
Fintan Kelleher* and Sinead Kelly
Reductive amination of primary amines with a proline derived aldehyde followed by thermal cyclisation in refluxing
toluene gave spirolactams in good yields.
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Abstract:
Proline derived [4.4]-spirolactams have been synthesised in good yields by a
reductive-amination reaction followed by thermal cyclisation of the resulting amine
onto the proline ester group in refluxing toluene. The synthesis of the corresponding
[4.5]-spirolactams by the same method gave much reduced yields.

There are currently a large number of methods for the synthesis of spirocyclic
compounds and they can also be easily formed in a stereocontrolled manner.1
Freidinger was the first to incorporate a lactam constraint into the backbone of a
peptide in order to rigidify the peptide tertiary structure into a more defined
conformation.2 One of the most common methods for the synthesis of lactams is the
cyclisation of an amino group (primary or secondary) onto a carboxylic ester, with
concomitant loss of an alcohol. The overall efficiency of the cyclisation is dependent
on the size of the ring being formed, the nature of the amino substitutent in the case of
a secondary amine, any substituents on the resulting ring and the structure of the alkyl
moiety of the ester group. Many of the reactions take place spontaneously at ambient
temperature, while others require heating in a suitable solvent.2b,3

L-Proline derived spirolactams have, in particular, been studied for their use in
constraining peptides with L-proline residues to mimic a -turn, a very important
component of peptide secondary structures. A number of different strategies have also
been used for the critical final cyclisation step to form the spirobicyclic lactam ring. 3-5
(Figure 1).
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As part of a program to synthesise both homochiral and racemic spirocycles we were
interested in the synthesis of both enantiomers of proline derived [4.4]-spirolactams, a
racemic synthesis allows both enantiomers to be accessible, with the possibility of
their resolution at a later stage by, for example, diastereoisomeric salt formation.6

The variety of different cyclisation methods used, along with their wide ranging
yields, prompted us to study one of the methods, the thermal cyclisation reaction, in
more detail in order to investigate whether it was a viable method for the synthesis of
a range of proline-derived [4.4]-spirolactams. We were interested in having
substituents already in place on the lactam nitrogen which would then allow for
further manipulation and derivatisation. Of course this would increase the steric
hindrance of the system and might have a detrimental effect on the yield of the
cyclisation reaction. This necessitated the synthesis of secondary amines for
subsequent cyclisation onto a carboxylic ester (Scheme 1).

Aldehyde 4 was prepared in 4 steps from L-proline by methyl ester formation, Boc
protection of the nitrogen, -allylation using LiHMDS as base with allyl bromide as
alkylating agent and oxidative cleavage of the alkene using OsO4/NaIO4. We found
that it was necessary to efficiently purify the aldehyde by column chromatography to
completely free it from any traces of osmium by-products as failure to do so led to
reduced yields in subsequent steps. Reductive amination of 4 with allyl amine in
ethanol, followed by treatment of the intermediate imine with NaBH4, gave the
required secondary amine spirolactam precursor 5a. Following the method of
Johnson,4e,5 an almost quantitative (99%) yield of the spirolactam 6a was obtained.
Although this cyclisation was very efficient, we encountered problems in the work-up
in removing excess DMF with a large number of extractions with water being
required. As a result we examined the use of a different solvent and refluxing toluene
was investigated for the cyclisation step. It was not necessary to purify the secondary
amine intermediate prior to cyclisation, but direct reaction of the crude product was
possible. Although the work-up procedure was now much simpler, the 66% yield
obtained was much reduced. When benzylamine was used in place of allyl amine,
using the same reaction cyclisation conditions (refluxing in toluene), the N-benzyl
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substituted spirolactam (6b) was obtained in a higher yield of 75% (in both cases the
cyclisation reactions were performed in the absence of any acids or bases).

In order to investigate the possibility of the use of more synthetically useful amines in
the cyclisation step (e.g. amino acids as the amine moiety), the reaction with glycine
methyl ester (the free amine was obtained by treatment of the HCl salt with 2 molar
equivalents of Hunig’s base) was initially attempted. In this case the bicyclic
spirolactam 6c was isolated in 90% yield. Since the syntheses of 6a and 6b were
conducted in the absence of added base, these reactions were then repeated in the
presence of 1 molar equivalent of Hunig’s base. Surprisingly, this resulted in reduced
yields of 50% and 61%, respectively, for 6a and 6b, compared to the reactions
performed in the absence of added base. The reason for this reduction in yield is as
yet unexplained.

We next examined the use of the thermal ester aminolysis method for the synthesis of
the homologous [4.5]-spirolactam analogues. This required the synthesis of the
homologated aldehyde 8 (Scheme 2), for subsequent reaction to form the spiro lactams, under the same conditions as used to prepare the [4.4]-spirolactams. The
aldehyde was prepared from 3 by hydroboration-oxidation of the alkene followed by
Swern oxidation7 of the resulting alcohol 7. Reductive amination of crude 8 with allyl
amine, and cyclisation in refluxing toluene, gave the required spiro -lactam 10a in
only 20% yield, the remainder being the uncyclised secondary amine cyclisation
precursor 11. The use of benzylamine in the synthesis of N-benzyl spiro -lactam 10b
gave no product after prolonged heating in refluxing toluene and only a 17% yield of
the product was obtained, after treatment of the N-benzyl secondary amine analogue
of 11, with sodium hydride in THF at reflux temperature. This was not unexpected
since, in general, the formation of 5-membered rings is thermodynamically more
favourable than the corresponding 6-membered ring analogues. Johnson4e,5 also found
a similar outcome when trying to use the thermal cyclisation method to synthesise the
[4.5.5]-analogue of the compound in Figure 1. In that case no cyclisation was
observed.
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The unsubstituted [4.5]-spirolactam N-H analogue was synthesised in order to see
how effective the thermal cyclisation of a primary amine onto an ester was in
preparing the homologous spirolactam. The primary amine 12 was prepared by
alkylation of 2 with the stabase-protected aminopropyl bromide, followed by
deprotection with potassium carbonate in methanol, and subsequent stirring at reflux
in toluene to induce cyclisation gave the spiro -lactam 9 in 30% overall yield from 2.
The N-allyl and N-benzyl derivatives (10a and 10b) were prepared by alkylation with
allyl and benzyl bromide respectively, using sodium hydride as base in THF.
Attempts to prepare the compound with a -CH2CO2Me (or the ethyl ester equivalent)
side-chain by alkylation of the lactam nitrogen with methyl bromoacetate or the more
reactive iodoacetate analogue were unsuccessful, with 9 being recovered unchanged,
in each case.

In conclusion, the thermal ester aminolysis method allows the preparation of a series
of N-substituted [4.4]-spirolactams in 60-70% overall yield starting from -allyl ester
3. The reactions have been scaled up to 10 g with no loss in yield. This route also
allows the introduction of the lactam nitrogen substituent at a late stage in the
synthesis and it proceeds from a common intermediate, namely aldehyde 4. Currently
we are studying the extension of this methodology to homochiral -substituted
amines and -amino acids. The presence of the second chiral centre will allow the
easy separation of the diastereoisomeric products. The results of these studies will be
reported in due course.

Typical procedure for spirolactamisation, exemplified by the synthesis of 6c. To a
stirred solution of glycine methyl ester hydrochloride (1.02 g, 8.10 mmol) in dry
methanol (10 ml) was added dropwise diisopropylethylamine (2.58 ml, 14.80 mmol),
followed by a solution of 4 in dry methanol (4 ml). After 3 h MgSO4 (0.53 g, 4.43
mmol) was added and stirring was continued for a further 2 h. The reaction was
cooled to -4 oC and sodium borohydride (0.45 g, 11.80 mmol) was added portionwise,
and the solution was stirred for 1 h and then saturated sodium hydrogen carbonate
solution (7 ml) and water (3 ml) were added. The solution was extracted with ethyl
acetate (3 x 20 ml), dried over MgSO4 and concentrated in vacuo. The residual oil
was stirred at reflux temperature in toluene (12 ml) for 16 h, allowed to cool to
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ambient temperature and concentrated in vacuo. The residue was chromatographed on
silica gel in 10% ethyl acetate/hexane to give 6c as a pale yellow oil (1.91 g, 90%). Rf
0.33, 60% ethyl acetate/hexane. IR (thin film): 2975, 1751, 1700, 1251 cm-1. 1H NMR
(CDCl3 300.4 MHz, two rotamers present) 4.66 (d, 0.5H, J = 17.7 Hz, -CH2CO2Me), 4.44 (d, 0.5H, J = 17.5 Hz, -CH2-CO2Me), 4.28 (d, 0.5H, J = 15.0 Hz, CH2-CO2Me), 3.97 (d, 0.5H, J = 14.5 Hz, -CH2-CO2Me), 3.75 (s, 3H, -CO2Me), 3.613.33 (m, 4H, pyrrolidine -CH2 and lactam -CH2), 2.78-2.25 (m, 2H, lactam -CH2),
2.15-1.83 (m, 4H, pyrrolidine-CH2 and -CH2), 1.45 and 1.41 (2 x s, 9H, t-butyl).
C NMR (CDCl3, 75.4 MHz) 175.3 (lactam carbonyl), 169.3 and 169.0 (ester
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carbonyl), 153.6 and 153.4 (Boc carbonyl), 80.0 and 79.6 (spiro-Cq), 66.5 (t-butyl
Cq), 52.1 (-CO2Me), 47.9 and 47.6 (CH2-CO2Me), 44.7 and 44.5 (lactam -CH2), 43.9
and 43.7 (lactam -CH2), 37.3 and 36.7 (lactam -CH2), 31.1 and 30.0 (pyrrolidine CH2), 28.4 (t-butyl CH3), 23.3 and 22.7 (pyrrolidine-CH2). Microanalysis: Found: C,
57.38; H, 7.86; N, 8.71%. Calculated for C15H24N2O5 : C, 57.68; H, 7.74; N, 8.97%.
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Figure 1: Cyclisation methods for proline-derived spirolactams.3-5
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